跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,480 条关于
“muscarinic acetylcholine M1 receptor”
全部
12,480
临床试验
6,025
药物
1,356
机构
30
资讯
5,069
2个月前
First In Vivo PET Evidence Reveals Widespread M1 Receptor Deficits in Living Schizophrenia Patients
23天前
FDA Clears IND for Neurocrine and Nxera's Oral M1 Agonist NBI-1117567 in Alzheimer's Cognition
去年
MapLight Therapeutics Initiates Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for Schizophrenia Treatment
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
去年
Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
Cobenfy Approved for Schizophrenia: A Novel Muscarinic Receptor Agonist
去年
Zai Lab's KarXT Receives NMPA Acceptance for Schizophrenia Treatment in China
去年
Bristol Myers Squibb Presents New COBENFY Data for Schizophrenia Treatment at Psych Congress
8个月前
China Approves COBENFY, First Novel Schizophrenia Therapy in Over 70 Years
第 1 页，共 507 页
上一页
下一页
